Negotiable: SRG: An opportunity for an experienced Molecular Biologist to join an established organisation working at the forefront of drug discovery. Greater Manchester, England

Competitive: Hyper Recruitment Solutions (HRS): Hyper Recruitment Solution are currently supporting a leading Cell and Gene Therapy Biotech based in central London with the hiring of an experience Next Generation... London

In agronomy/statistics, molecular/cellular biology, or related field within plant sciencesStrong knowledge of variety/trait development principles and genetic…
From Land O’Lakes, Inc. - Tue, 15 Jun 2021 09:20:23 GMT - View all Kiel, WI jobs

Working knowledge of relevant statistical analysis and quantitative genetic analysis. Use of sequence analysis software and bioinformatics tools.
From Land O’Lakes, Inc. - Tue, 15 Jun 2021 09:20:23 GMT - View all Howard Lake, MN jobs

In agronomy/statistics, molecular/cellular biology, or related field within plant sciencesStrong knowledge of variety/trait development principles and genetic…
From Land O’Lakes, Inc. - Tue, 15 Jun 2021 09:20:23 GMT - View all Black River Falls, WI jobs

Working knowledge of relevant statistical analysis and quantitative genetic analysis. Use of sequence analysis software and bioinformatics tools.
From Land O’Lakes, Inc. - Tue, 15 Jun 2021 09:20:23 GMT - View all Neosho, MO jobs

Notice NOT-NR-21-003 from the NIH Guide for Grants and Contracts

Notice NOT-AG-21-027 from the NIH Guide for Grants and Contracts

Assist senior scientist(s) in experimentation: preparation, data collection, analysis and reporting. Experience with analyzing and reporting data using…
From Perfectus Biomed - Mon, 14 Jun 2021 18:42:10 GMT - View all Jackson, WY jobs

Notice NOT-HG-21-034 from the NIH Guide for Grants and Contracts

Funding Opportunity PAS-21-245 from the NIH Guide for Grants and Contracts. Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial not allowed)

Funding Opportunity PAR-21-243 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for investigator-initiated multi-site clinical trials (e.g. efficacy, effectiveness or pragmatic trials) to study the effects of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) in NCCIH designated areas of high research priority. Clinical Coordinating Centers should develop and implement the proposed fully powered multi-site clinical trial. The objective of a Clinical Coordinating Center application is to present the scientific rationale and a comprehensive scientific and operational plan for the clinical trial. Clinical Coordinating Center applications are expected to describe plans for project management, participant recruitment and retention strategies, performance milestones, scientific conduct, and dissemination of results. Clinical Coordinating Center applications submitted under this FOA will utilize a two-phase, milestone-driven cooperative agreement (UG3/UH3) funding mechanism. In addition, an accompanying Data Coordinating Center application, submitted under PAR-XX-XXX proposing a data analysis and data management plan for the clinical project is required. Both a Clinical Coordinating Center application and a corresponding Data Coordinating Center (DCC) application need to be submitted simultaneously for consideration by NCCIH. For additional information about the mission, strategic vision, and research priorities of the NCCIH, applicants are encouraged to consult the NCCIH website: (https://nccih.nih.gov/about/plans). Applicants are encouraged to contact the appropriate the Scientific/Research contact for the area of science for which they are planning to develop an application prior to submitting to this FOA.

Funding Opportunity PAR-21-242 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA), utilizing the U24 grant funding mechanism, encourages applications for a collaborating Data Coordinating Center (DCC) application that accompanies an investigator-initiated multi-site clinical trial (Phase Ill and beyond) application submitted under TEMP-12554. The DCC application must be specific to the collaborating Clinical Coordinating Center (CCC) application. The objective of the DCC application is to propose a comprehensive plan that provides overall project coordination, and administrative, data management, and biostatistical support for the proposed clinical trial. Both a DCC application and a corresponding CCC application need to be submitted simultaneously for consideration by NCCIH. Trials for which this FOA applies must be relevant to the research mission of the NCCIH and considered a high priority by the Center. For additional information about the mission, strategic vision, and research priorities of the NCCIH, applicants are encouraged to consult the NCCIH website: (http://www.nccih.nih.gov). Applicants are encouraged to contact the appropriate the Scientific/Research contact for the area of science for which they are planning to develop an application prior to submitting to this FOA.

Funding Opportunity PAR-21-241 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for investigator-initiated clinical trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) in NCCIH-designated areas of high research priority. Applications submitted under this FOA are expected to propose a multi-site clinical trial to assess whether the intervention can be delivered with fidelity across sites; demonstrate feasibility of recruitment, accrual, and randomization of participants across sites; demonstrate participant adherence to the intervention, as well as retention of participants throughout the study across sites; and/or demonstrate feasibility of data collection across sites in preparation for a future multi-site trial. The need for multi-site feasibility trials are expected to be justified by sufficient preliminary data from previous single site feasibility or acceptability trial(s)or the published literature. This FOA will not support randomized clinical trials to determine efficacy or effectiveness. The data collected should be used to fill gaps in scientific knowledge necessary to develop a competitive fully powered multi-site clinical trial that has the potential to make a significant impact on public health Applicants are encouraged to contact the appropriate NCCIH Scientific/Research contact for the area of science for which they are planning to develop an application prior to submitting to this FOA..

Funding Opportunity PAR-21-240 from the NIH Guide for Grants and Contracts. The goal of this funding opportunity is to support early phase clinical trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) for conditions that have been identified by NCCIH as high priority research topics. This funding opportunity is intended to support feasibility clinical trials, which will provide data that are critical for the planning and design of a subsequent controlled cohort study, clinical efficacy or effectiveness study, or a pragmatic trial. The data collected should be used to fill gaps in scientific knowledge necessary to develop a competitive full-scale clinical trial, including, but not limited to the following: examining feasibility and acceptability of interventions lacking published data; adapting an intervention to a specific population; refining the intervention to determine the most appropriate frequency or duration; determining feasibility of recruitment, retention and data collection procedures; refining and assessing the feasibility of protocolized multimodal interventions; or examining acceptability and adherence of control conditions. This FOA will not support randomized clinical trials to test or determine efficacy or effectiveness; nor will this FOA support repetition of feasibility or acceptability research that has been previously conducted in the same or similar patient population with the same or similar intervention. Applications that propose solely to write a protocol or manual of operations or to develop infrastructure for a clinical trial are not appropriate for this announcement. The subsequent larger trial should have the potential to make a significant impact on public health.

GBP50000.00 - GBP60000.00 per annum: SRG: Assay Development - NGS Oxfordshire, England

Conduct analysis and procedures to improve scientific understanding and presentation of the relationships among genetic and genomic parameters and dairy… $53,433 - $84,049 a year
From usajobs.gov - Fri, 11 Jun 2021 15:46:51 GMT - View all Madison, WI jobs

Notice NOT-DC-21-003 from the NIH Guide for Grants and Contracts

GBP20000.00 - GBP30000.00 per annum: SRG: Biochemistry Associate Scientist Oxfordshire, England

Notice NOT-DC-21-004 from the NIH Guide for Grants and Contracts